0000899243-20-031554.txt : 20201118
0000899243-20-031554.hdr.sgml : 20201118
20201118194256
ACCESSION NUMBER: 0000899243-20-031554
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KORMAN HARRY
CENTRAL INDEX KEY: 0001197548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39695
FILM NUMBER: 201326686
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE
STREET 2: MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viatris Inc
CENTRAL INDEX KEY: 0001792044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 834364296
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
BUSINESS PHONE: (724) 514-1465
MAIL ADDRESS:
STREET 1: 1000 MYLAN BOULEVARD
CITY: CANONSBURG
STATE: PA
ZIP: 15317
FORMER COMPANY:
FORMER CONFORMED NAME: Upjohn Inc
DATE OF NAME CHANGE: 20191023
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-16
0
0001792044
Viatris Inc
VTRS
0001197548
KORMAN HARRY
1000 MYLAN BOULEVARD
CANONSBURG
PA
15317
1
0
0
0
Common Stock
2020-11-16
4
A
0
26515
A
26701
D
Employee Stock Option - Right to Buy
22.66
2020-11-16
4
A
0
4413
A
2021-03-02
Common Stock
4413
4413
D
Employee Stock Option - Right to Buy
23.44
2020-11-16
4
A
0
4266
A
2022-02-22
Common Stock
4266
4266
D
Employee Stock Option - Right to Buy
55.84
2020-11-16
4
A
0
12555
A
2024-03-05
Common Stock
12555
12555
D
Non-Employee Director Stock Option - Right to Buy
36.14
2020-11-16
4
A
0
3446
A
2028-06-29
Common Stock
3446
3446
D
Non-Employee Director Stock Option - Right to Buy
27.45
2020-11-16
4
A
0
4352
A
2029-03-01
Common Stock
4352
4352
D
Non-Employee Director Stock Option - Right to Buy
17.48
2020-11-16
4
A
0
6151
A
2030-03-02
Common Stock
6151
6151
D
Restricted Stock Units
0.00
2020-11-16
4
A
0
9440
A
Common Stock
9440
9440
D
On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
Includes 186 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend.
Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination.
These options vested on March 2, 2014.
These options vested on February 22, 2015.
These options vested on March 5, 2017.
These options vested on March 2, 2019.
These options vested on March 2, 2020.
These options will vest on March 2, 2021.
Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination.
Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021.
/s/ Kevin Macikowski, by power of attorney
2020-11-18